Can Multiple Myeloma Be Cured? What Today’s Most Successful Treatments Can Do

Multiple myeloma treatment has changed more in the last few years than in the decades before. Patients and families now ask a question that once had a simple answer: can multiple myeloma be cured?

Today's most successful treatments for multiple myeloma, including four-drug combinations and the newest treatments approved in 2025 and 2026, can put many patients into a deep remission with no detectable disease. This guide explains what experts mean by a cure, what it takes to reverse multiple myeloma's course, and how to get the right cancer care for multiple myeloma.

Can Multiple Myeloma Be Cured?

Multiple myeloma is still not generally considered curable, but that answer is changing. Current treatment strategies already produce what researchers call "exceptional responders": roughly 30% of patients whose myeloma has not progressed eight or more years after treatment.

Myeloma experts now talk about a functional cure: a deep, long-term remission with no evidence of disease that lasts even after treatment stops. At the 2025 meeting of the International Myeloma Society, a leading myeloma researcher predicted that a functional cure could become achievable within the next decade. Whether a given patient can reach it depends on the type of myeloma and how it responds to treatment, which is why the goal of treatment is worth discussing with your care team from the start.

What Is the Most Successful Treatment for Multiple Myeloma?

For people starting treatment for the first time, the most successful treatments today combine four drugs, often called a quadruplet. A typical combination pairs a monoclonal antibody with a proteasome inhibitor, an immunomodulatory drug and a steroid. In randomized studies, these four-drug combinations produced deeper responses and longer disease control than earlier three-drug combinations.

The options keep widening. In January 2026, the FDA expanded the approval of daratumumab and hyaluronidase (Darzalex Faspro) with bortezomib, lenalidomide and dexamethasone to patients starting first treatment who are not candidates for a stem cell transplant, so more people can start with a four-drug combination. For patients who are candidates, a transplant using their own cells may follow initial treatment.

Can You Reverse Multiple Myeloma?

Treatment can't erase myeloma, but it can push it so far back that tests no longer find it. Doctors describe this in levels:

Complete response: standard tests no longer detect myeloma.
MRD negativity: a highly sensitive test of the bone marrow finds no myeloma cells, at a level as fine as one cell in a million. MRD stands for minimal (or measurable) residual disease.
Sustained MRD negativity: MRD negativity that holds over time. Researchers see this as the strongest signal that remission will last.

Modern four-drug treatment already brings 20% to 27% of patients to the deepest MRD level, and adding more treatment afterward may raise that further. Some studies now use MRD results to decide when treatment can stop. In one trial, most patients who reached sustained MRD negativity were moved off therapy and remained treatment-free during follow-up.

The Newest Treatments for Multiple Myeloma

When myeloma returns after earlier treatment, there are now more options than ever. Recent FDA approvals include:

Linvoseltamab (Lynozyfic), July 2025: a bispecific antibody that directs the body's own T cells to attack myeloma cells, for adults who have had at least four earlier lines of treatment. In its trial, 70% of patients responded and 45% had a complete response, meaning tests no longer detected cancer.
Belantamab mafodotin (Blenrep), October 2025: given with bortezomib and dexamethasone, for adults who have had at least two earlier lines of treatment.
Daratumumab (Darzalex Faspro), November 2025: approved on its own for high-risk smoldering myeloma, an early form that has not yet become active disease.

Each of these has its own schedule and side effects, so the newest treatment is not automatically the right next step. Your care team weighs what you have already received and how your myeloma responded.

Getting the Right Cancer Care for Multiple Myeloma

Myeloma care moves quickly, so it helps to be treated by, or get a second opinion from, a doctor who focuses on myeloma. Ask whether the center offers four-drug combinations, sensitive MRD testing and clinical trials.

Timing can also affect which options are open to you. Our guide to multiple myeloma treatment timing explains why, and our checklist of what to review before choosing care can help you prepare.

Questions to Ask Your Care Team

What is the goal of my treatment: control, or the deepest remission possible?
Am I a candidate for a four-drug combination?
Will you test for MRD, and how will the results guide my treatment?
If my myeloma returns, which of the newest treatments might fit me?
Is there a clinical trial I could join?

Frequently Asked Questions

Can multiple myeloma be cured?

It is not generally considered curable yet, but a growing share of patients reach deep, lasting remissions, and some stay free of progression for many years. Experts describe a functional cure, long-term remission without ongoing treatment, as a realistic goal for the coming years.

How do you reverse multiple myeloma?

Treatment can drive myeloma into remission, ideally to the point that even sensitive MRD tests find no myeloma cells. Four-drug combinations and newer immune-based treatments are the main tools.

What is the newest treatment for multiple myeloma?

Recent approvals include linvoseltamab (July 2025) and belantamab mafodotin (October 2025) for myeloma that has returned, and an expanded approval of a four-drug combination for patients starting first treatment (January 2026).

What is the most successful treatment for multiple myeloma?

For patients starting first treatment, four-drug combinations built around a monoclonal antibody currently produce the deepest responses. The right choice depends on your health and whether a transplant is an option.

Final Thoughts

Multiple myeloma is not yet considered curable, but the newest treatments are bringing more patients to deep, lasting remission than ever before. Ask your care team about the goal of your treatment, MRD testing, and whether a four-drug combination or a newer option fits your situation.

This article is general information, not medical advice. Talk with your doctor or care team about your own treatment.